These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1606069)

  • 1. Europeans still undecided on chemoprevention for breast cancer.
    Ann Oncol; 1992 Jan; 3(1):5-6. PubMed ID: 1606069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemoprevention of breast cancer: a hope justified?].
    Buser K; Delaloye JF
    Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of breast cancer with tamoxifen.
    Cuzick J
    IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen infrequently used by women at risk for breast cancer.
    Dreyfuss JH
    CA Cancer J Clin; 2010; 60(4):204-6. PubMed ID: 20530798
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Italian study on the chemoprevention of breast cancer with tamoxifen].
    Veronesi U; Costa A; Sacchini V; Luini A; Bonanni B; Veronesi P; Rotmensz N; Boyle P
    Contracept Fertil Sex; 1995 Apr; 23(4):258-60. PubMed ID: 7757133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of breast cancer.
    De Palo G; Costa A; Formelli F; Del Vecchio M; Marubini E; Veronesi U
    In Vivo; 1993; 7(6B):577-80. PubMed ID: 8193278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer - pilot analysis.
    Layeequr Rahman R; Crawford S
    Breast; 2009 Oct; 18(5):289-93. PubMed ID: 19716702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of breast cancer.
    Bonte J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():141-5. PubMed ID: 8298444
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoprevention of breast cancer: a promising idea with an uncertain future.
    Kinsinger LS; Harris R
    Lancet; 2002 Sep; 360(9336):813-4. PubMed ID: 12243912
    [No Abstract]   [Full Text] [Related]  

  • 12. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
    Kondo M; Hoshi SL; Toi M
    Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention: a new strategy in the fight against breast cancer?].
    Bercheme G; Ries F; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1993; 130(1):5-9. PubMed ID: 8222016
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoprevention trends in breast cancer.
    Lazzaro M; Mizell V; Thompson M; Weber D
    Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
    Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of breast cancer.
    O'Regan RM
    Lancet; 2006 Apr; 367(9520):1382-3. PubMed ID: 16650636
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision analysis of tamoxifen for the prevention of invasive breast cancer.
    Grann VR; Sundararajan V; Jacobson JS; Whang W; Heitjan DF; Antman KH; Neugut AI
    Cancer J; 2000; 6(3):169-78. PubMed ID: 10882333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.